Veradermics Incorporated (MANE:NYSE) closed at $138.78 on October 23, 2026, up 0.21% on the day. The stock trades 2.1% below its 52-week high of $141.75 and 333.7% above its 52-week low of $32.00. Over the past year, it gained 267.6%. Veradermics Incorporated is part of the Health Care sector.
In 181 trading sessions since February 5, 2026, MANE closed higher on 101 days (56%). Its best day was April 27, 2026 (+47.55%) and its worst was July 16, 2026 (-14.45%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for pattern hair loss, a condition affecting approximately 50 million men and 30 million women in the United States.
Find more stocks like MANE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.